Too bad Martha Stewart and Sam Waksal weren't more patient with their investments in scandal-plagued ImClone Systems Inc. On Monday, the company's share price soared past pre-scandal levels and ...

TRENTON, N.J. — Biotechnology company ImClone Systems Inc. said Wednesday it is considering a buyout offer worth $70 per share from an unidentified large pharmaceutical company, and rejected a ...

NEW YORK, July 23 -- Congressional investigators today requested more documents from Merrill Lynch & Co. regarding alleged insider trading in shares of biopharmaceutical firm ImClone Systems Inc ...

ImClone Systems yesterday said it turned down a $36-a-share bid last month from a major drugmaker, after billionaire investor Carl Icahn opposed the sale. Icahn, locked in a battle with ImClone ...

BOSTON (Reuters) - ImClone Systems Inc said on Wednesday it has received a takeover offer of $70 a share from a large pharmaceutical company, topping an earlier bid of $60 a share from Bristol ...

Lilly commences tender offer for ImClone Systems at $70 per share: Indianapolis Thursday, October 16, 2008, 08:00 Hrs [IST] Eli Lilly and Company announced that its wholly-owned subsidiary, Alaska ...

NEW YORK -- A New Year's Eve stock decline widened as the session wound toward its end, leaving the Dow Jones Industrial Average with one gainer on the day among its 30 members: Honeywell ...

ImClone Systems’ share price surged by more than 18% on the Nasdaq Stock Exchange yesterday after clinical data showed that the firm’s oncology drug, Erbitux (cetuximab), used in combination with ...

ImClone Systems Inc <IMCL.O> said on Wednesday it has received a takeover offer of $70 a share from a large pharmaceutical company, topping an earlier bid of $60 a share from Bristol-Myers Squibb ...